Literature DB >> 6263769

[Capillary embolization. Part I: occlusion of the entire arterial system of the rat kidney (author's transl)].

J Rassweiler, G W Kauffmann, R Rohrbach, G Richter.   

Abstract

Effect of tumor embolization is limited by parasitary blood supply. The influence of those collaterals should be decreased by transporting the embolization medium into the capillaries and tumor sinusoids. Controlled and safe capillary embolization is developed from studies of obtainable radiodensity, viscosity, and occlusion mechanism of Gelfoam-powder, IBC, and Ethibloc. The efficiency of these substances is compared to simple arterial ligation in experimental series with 400 Wistar rats. It is shown that ligation is comparable to insufficient capillary transport of the medium leaving islands of microscopically intact parenchyma. Easy application and total necrosis is guaranteed only by Ethibloc. Success of embolization is strictly volume dependent. Preinjected glucose is mandatory for homogenous distribution and peripheral transport.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6263769     DOI: 10.1055/s-2008-1056808

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  4 in total

1.  Homologous controlled-viscosity fibrin for endovascular embolization. Part II: catheterization technique, animal experiments.

Authors:  B Richling
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

2.  [Blunt kidney injuries - operative or conservative therapy? A contribution to classification].

Authors:  J Rassweiler; F Eisenberger; J Buck
Journal:  Unfallchirurgie       Date:  1983-10

3.  Prolonged survival following palliative renal tumor embolization by capillary occlusion.

Authors:  G W Kauffmann; G M Richter; R Rohrbach; W Wenz
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Jan-Feb       Impact factor: 2.740

4.  Embolization with "Ethibloc" of vascular tumors and arteriovenous malformations in the head and neck.

Authors:  D Kühne; K Helmke
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.